Search
for
Sort by
Research 151–180 of 1000+
- A 36-Year-Old Woman With an Unexpected Cause of Hypokalemia
- Serum level of Alarin in Patients with Androgenetic Alopecia
- Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons
- A Study of Correlation of Alopecia Areata and Metabolic Syndrome in Northwest Indian Population
- The role of high serum uric acid levels in androgenic and non-androgenic polycystic ovarian syndrome patients
- Finasteride
- Biochemical and Structural Characteristics, Gene Regulation, Physiological, Pathological and Clinical Features of Lipocalin-Type Prostaglandin D2 Synthase as a Multifunctional Lipocalin
- Effect of Fermented Camel Milk Containing Pumpkin Seed Milk on the Oxidative Stress Induced by Carbon Tetrachloride in Experimental Rats
- Recent advances in the molecular mechanisms causing primary generalized glucocorticoid resistance
- Evaluation of cardiovascular disease risk factors in patients with mycosis fungoides
- Weight loss regimens that control for carbohydrate quality or quantity: a review
- The Role of Individually Selected Diets in Obese Women with PCOS—A Review
- Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes
- Menopause and hair loss in women: Exploring the hormonal transition
- Lean Women with Polycystic Ovary Syndrome
- Evaluation of Insulin Resistance Markers in Polycystic Ovary Syndrome Patients Receiving Metformin, Finasteride or Both
- Identification of VLDL as a biomarker for prewarning of androgenic alopecia
- Body Fat Distribution in Thai Reproductive-Aged Polycystic Ovary Syndrome Women Compared with Non-Polycystic Ovary Syndrome Women
- Causal Effects of Lipids-Related Metabolites on Androgenic Alopecia: A Mendelian Randomization Study
- Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence
- Effectiveness of micronutrient rich supplement on the symptoms of polycystic ovarian syndrome among reproductive age women
- Is Early-onset Androgenetic Alopecia Associated with Metabolic Syndrome? – A Descriptive Cross-sectional Study
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
- Clinical profile of androgenic alopecia and its association with cardiovascular risk factors
- Author response: Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- Patient-reported outcomes, provider-reported outcomes, and physiologic parameters after gender-affirming hormone treatment in Canada: a systematic review
- Decision letter: Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- Safety of testosterone use in women
- The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men
- Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence